These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8389574)

  • 1. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells.
    Couture LA; Lehman JM
    Int J Dev Biol; 1993 Mar; 37(1):125-33. PubMed ID: 8389574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trans-acting factor represses the activity of the polyoma virus enhancer in undifferentiated embryonal carcinoma cells.
    Sassone-Corsi P; Fromental C; Chambon P
    Oncogene Res; 1987 Jul; 1(2):113-9. PubMed ID: 2835729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors.
    Furukawa K; Yamaguchi Y; Ogawa E; Shigesada K; Satake M; Ito Y
    Cell Growth Differ; 1990 Mar; 1(3):135-47. PubMed ID: 1964077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of polyomavirus mutants multiadapted to murine embryonal carcinoma cells.
    Melin F; Pinon H; Kress C; Blangy D
    J Virol; 1985 Mar; 53(3):862-6. PubMed ID: 2983095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficiency DNA transfection in murine embryonal carcinoma cells: expression of pSV3neo in wild type and retinoid-resistant cell lines.
    Purpus EJ; McCue PA
    Int J Dev Biol; 1993 Mar; 37(1):117-24. PubMed ID: 8389573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host range specificity of polyomavirus EC mutants in mouse embryonal carcinoma and embryonal stem cells and preimplantation embryos.
    Mélin F; Kemler R; Kress C; Pinon H; Blangy D
    J Virol; 1991 Jun; 65(6):3029-43. PubMed ID: 1851869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature dependent expression of polyoma virus in murine embryonal carcinoma cells.
    Dandolo L; Vasseur M; Kress C; Aghion J; Blangy D
    J Cell Physiol; 1980 Oct; 105(1):17-24. PubMed ID: 6253510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells.
    Vasseur M; Kress C; Montreau N; Blangy D
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1068-72. PubMed ID: 6244578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common features of polyomavirus mutants selected on PCC4 embryonal carcinoma cells.
    Melin F; Pinon H; Reiss C; Kress C; Montreau N; Blangy D
    EMBO J; 1985 Jul; 4(7):1799-803. PubMed ID: 2992943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.
    Katinka M; Vasseur M; Montreau N; Yaniv M; Blangy D
    Nature; 1981 Apr; 290(5808):720-2. PubMed ID: 6261151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the interaction of polyoma virus and simian virus 40 with embryonal carcinoma cells.
    Hales K; Lehman JM
    Exp Mol Pathol; 1987 Aug; 47(1):48-58. PubMed ID: 3038593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.
    Zhang S; Magnusson G
    J Virol; 2001 Nov; 75(21):10015-23. PubMed ID: 11581370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.